logo
12:59 Feb 26

Lincoln Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
623.25
+11.00 (+1.80%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Lincoln Pharmaceuticals Ltd. Financials

Lincoln Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
623.25
+11.00 (+1.80%)
12:59 Feb 26
Quality
image/svg+xml

55/100
High Financial Strength

Valuation
image/svg+xml

46/100
Mid Valuation

Technical

56/100
Technically Neutral

Strength

13

Weakness

1

Opportunity

0

Threats

0

12.25 %

ROE %

10.33 %

ROA %

43.85

EPS

335.34

BVPS

13.21 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
472.12 510.31 580.55 623.23 651.93
Operating Expenses +
376.64 421.1 480.65 521.74 552.39
Raw Material
232.15 245.64 284.03 282.48 297.11
Increase Decrease in Cost
-13.57 -4.24 -5.7 8.84 5.13
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
70.47 93.16 102.9 112.45 120.36
Miscellaneous Expenses
234.93 223.82 265.24 255.05 129.79
Operating Profit
95.48 89.21 99.9 101.49 99.54
Other Income
10 22.47 34.42 22.48 30.77
Depreciation
8.09 9.17 10.62 12.9 14.05
Interest
1.45 2.03 1.46 1.88 1.11
Profit before tax and exceptio..
95.94 100.48 122.24 109.19 115.15
Exceptional Items
0 0 0 0 0
PBT
95.94 100.48 122.24 109.19 115.15
Provision for Taxation
26.58 27.58 28.94 26.84 27.33
Net Profit
69.36 72.9 93.3 82.35 87.84
NET Profit after MI
69.36 72.9 93.3 82.35 87.84
EPS
34.63 36.4 46.58 41.11 43.86
Operating Profit Margin (%)
20.22 17.48 17.21 16.28 15.27
Net Profit Margin (%)
14.69 14.29 16.07 13.21 13.47

Lincoln Pharmaceuticals Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 49.80 49.80 49.80 49.80 49.80 49.80
FII 4.70 4.70 5.10 5.00 5.20 5.20
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 45.50 45.50 45.10 45.20 45.00 45.00
Shareholder Shares Holding %
Research 360 logo
Download Our App On: